| Phase I: At-Home Support for Rural Women Using Group Video Calling (NCT01672684) | Stanford University | 2012-10-01 |
| Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT01742637) | Sun Pharmaceutical Industries, Inc. | 2012-10-01 |
| A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers (NCT01711801) | Hoffmann-La Roche | 2012-10-01 |
| Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies (NCT01688960) | Regeneron Pharmaceuticals | 2012-10-01 |
| Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions (NCT01831700) | IPCA Laboratories Ltd. | 2012-10-01 |
| Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors (NCT01217450) | National Cancer Institute (NCI) | 2012-10-01 |
| A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects (NCT01635751) | GL Pharm Tech Corporation | 2012-10-01 |
| Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects (NCT01705938) | Bausch Health Americas, Inc. | 2012-10-01 |
| Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers (NCT01691924) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2012-10-01 |
| Effects of Dietary Nitrate on Age-related Vascular Function (NCT01729234) | Heinrich-Heine University, Duesseldorf | 2012-10-01 |
| Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study (NCT01702324) | Fortuderm Ltd. | 2012-10-01 |
| Pharmacokinetic Interactions Between Atorvastatin and Metformin in Healthy Male Subjects (NCT01765023) | HK inno.N Corporation | 2012-10-01 |
| Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects (NCT01813461) | Astellas Pharma Global Development, Inc. | 2012-10-01 |
| Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant (NCT01774435) | Endo USA Inc., a Keenova Therapeutics Company | 2012-10-01 |
| Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures (NCT01673087) | University of Michigan | 2012-10-01 |
| Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers (NCT01707940) | Boehringer Ingelheim | 2012-10-01 |
| Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults (NCT02478281) | American Regent, Inc. | 2012-10-01 |
| A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD. (NCT01703845) | Boehringer Ingelheim | 2012-10-01 |
| Safety and Feasibility Study of Umbilical Cord Blood Mononuclear Cells Transplant to Treat Ischemic Stroke (NCT01673932) | China Spinal Cord Injury Network | 2012-10-01 |
| Pharmacology of Exenatide in Pediatric Sepsis (NCT01573806) | Seattle Children's Hospital | 2012-10-01 |
| Cisplatin + RT for Triple Negative Breast Cancer (NCT01674842) | Dana-Farber Cancer Institute | 2012-10-01 |
| Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study (NCT02100592) | Ospedale Generale Di Zona Moriggia-Pelascini | 2012-10-01 |
| Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients (NCT01311570) | Shalvata Mental Health Center | 2012-10-01 |
| Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786) (NCT01720576) | Regeneron Pharmaceuticals | 2012-10-01 |
| A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours (NCT01668550) | Cancer Research UK | 2012-10-01 |
| Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use (NCT01631383) | University of Maryland, Baltimore | 2012-10-01 |
| Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects (NCT01703832) | Biologische Heilmittel Heel GmbH | 2012-10-01 |
| Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer (NCT01545141) | Roswell Park Cancer Institute | 2012-10-01 |
| Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects (NCT01757756) | Pfizer | 2012-10-01 |
| Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia (NCT01919710) | Tianjin SinoBiotech Ltd. | 2012-10-01 |
| A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects (NCT01793649) | Gilead Sciences | 2012-10-01 |
| Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules (NCT01704846) | Boehringer Ingelheim | 2012-10-01 |
| A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16 (NCT01704040) | Janssen Research & Development, LLC | 2012-10-01 |
| Oral Nitrite and Nitrate in Healthy Normal Volunteer Adults (NCT01681836) | Gladwin, Mark, MD | 2012-10-01 |
| Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors. (NCT01705002) | Lipomedix Pharmaceuticals Inc. | 2012-10-01 |
| Exercise in Severely Disabled Patients With MS (NCT01752660) | University of Aarhus | 2012-10-01 |
| Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD) (NCT01616290) | Proteon Therapeutics | 2012-10-01 |
| A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974) (NCT01650727) | Merck Sharp & Dohme LLC | 2012-10-01 |
| Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals (NCT01712425) | IrsiCaixa | 2012-10-01 |
| Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models (NCT01615510) | University Hospital Schleswig-Holstein | 2012-10-01 |
| Thrombolysis in Pediatric Stroke (TIPS) (NCT01591096) | Seattle Children's Hospital | 2012-10-01 |
| Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer (NCT01727869) | Regeneron Pharmaceuticals | 2012-10-01 |
| A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy (NCT01668017) | Merck KGaA, Darmstadt, Germany | 2012-09-30 |
| Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT01642251) | National Cancer Institute (NCI) | 2012-09-28 |
| A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma (NCT01343043) | GlaxoSmithKline | 2012-09-27 |
| Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers (NCT01725672) | GlaxoSmithKline | 2012-09-27 |
| PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma (NCT01621490) | Bristol-Myers Squibb | 2012-09-27 |
| A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) (NCT01691898) | Genentech, Inc. | 2012-09-27 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects (NCT01696604) | GlaxoSmithKline | 2012-09-26 |
| Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) (NCT01306019) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-09-25 |
| Metformin in Children With Relapsed or Refractory Solid Tumors (NCT01528046) | H. Lee Moffitt Cancer Center and Research Institute | 2012-09-24 |
| Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer (NCT01602406) | Novartis Pharmaceuticals | 2012-09-21 |
| Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients (NCT02028442) | Akamis Bio | 2012-09-20 |
| A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies (NCT01682473) | Zenyaku Kogyo Co., Ltd. | 2012-09-20 |
| Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes (NCT01686945) | Novo Nordisk A/S | 2012-09-19 |
| A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212 (NCT01658553) | GlaxoSmithKline | 2012-09-19 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002) (NCT01640873) | Merck Sharp & Dohme LLC | 2012-09-19 |
| Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets (NCT01687920) | Bayer | 2012-09-17 |
| Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia (NCT01588522) | BPGbio | 2012-09-17 |
| Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer (NCT01629498) | M.D. Anderson Cancer Center | 2012-09-17 |
| Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects (NCT01690169) | Novo Nordisk A/S | 2012-09-14 |
| Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease (NCT01685216) | Shire | 2012-09-14 |
| BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to Relapse (NCT01690624) | Boehringer Ingelheim | 2012-09-13 |
| A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms (NCT01704963) | Janssen Pharmaceutical K.K. | 2012-09-12 |
| Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM) (NCT01634750) | National Human Genome Research Institute (NHGRI) | 2012-09-11 |
| Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer (NCT01496157) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-11 |
| Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer (NCT01664754) | Jonsson Comprehensive Cancer Center | 2012-09-07 |
| Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer (NCT01683994) | National Cancer Institute (NCI) | 2012-09-07 |
| P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. (NCT01591421) | Canadian Cancer Trials Group | 2012-09-06 |
| Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors (NCT01642342) | University of Southern California | 2012-09-06 |
| A Phase 1/2 Study to Evaluate MEDI4736 (NCT01693562) | MedImmune LLC | 2012-09-05 |
| Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (NCT01250470) | Roswell Park Cancer Institute | 2012-09-05 |
| Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy (NCT01649258) | University of Southern California | 2012-09-04 |
| An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT01711697) | Emory University | 2012-09-04 |
| A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors (NCT01340846) | GlaxoSmithKline | 2012-09-03 |
| Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation (NCT00877955) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-09-01 |
| Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes (NCT02686281) | Genmedica Therapeutics S.L. | 2012-09-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers (NCT01688089) | Orion Corporation, Orion Pharma | 2012-09-01 |
| Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients (NCT01657214) | Sanofi | 2012-09-01 |
| Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer (NCT01623349) | Dana-Farber Cancer Institute | 2012-09-01 |
| Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants (NCT01700179) | Alexion Pharmaceuticals, Inc. | 2012-09-01 |
| Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis (NCT01724697) | Air Force Military Medical University, China | 2012-09-01 |
| Mismatched Donor Cells to Treat Acute Myeloid Leukemia (NCT01793025) | Maisonneuve-Rosemont Hospital | 2012-09-01 |
| A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving (NCT01684150) | Epizyme, Inc. | 2012-09-01 |
| A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease (NCT01680991) | Hoffmann-La Roche | 2012-09-01 |
| GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans (NCT02731664) | Uppsala University | 2012-09-01 |
| Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis (NCT01687179) | Brigham and Women's Hospital | 2012-09-01 |
| A Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib in Multiple Non Operable Brain Metastases (NCT01551680) | Institut du Cancer de Montpellier - Val d'Aurelle | 2012-09-01 |
| Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents (NCT01689324) | Sanofi Pasteur, a Sanofi Company | 2012-09-01 |
| Reducing High Risk Behavior in Treatment Court (NCT01481428) | Treatment Research Institute | 2012-09-01 |
| Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer (NCT03480750) | National Cheng-Kung University Hospital | 2012-09-01 |
| Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients (NCT01702285) | Curis, Inc. | 2012-09-01 |
| To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594 (NCT01636024) | AstraZeneca | 2012-09-01 |
| A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (NCT01666652) | U.S. Army Medical Research and Development Command | 2012-09-01 |
| The Impact of RPh201 on Chronic Vegetative State (CVS): fMRI Study (NCT01438684) | Hadassah Medical Organization | 2012-09-01 |
| Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. (NCT02862288) | Centre Hospitalier Universitaire de Besancon | 2012-09-01 |
| Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects (NCT02111070) | Il-Yang Pharm. Co., Ltd. | 2012-09-01 |
| PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual (NCT01800305) | Xiamen Amoytop Biotech Co., Ltd. | 2012-09-01 |
| Negative Pressure Dressing After Saphenous Vein Harvest (NCT01698372) | University of Calgary | 2012-09-01 |
| Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus (NCT01676233) | Sanofi | 2012-09-01 |